Based on market data through Oct 30, 2026, StockInvest.us rates Kala Pharmaceuticals Inc (KALA) as a Strong Sell Candidate with a technical score of -5.41 on its -10 to +10 scale. The rating is ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Ka Vang is a writer, playwright and children’s book author. She is the vice president of equity and community impact for Meet Minneapolis, the tourism, convention and visitors’ bureau for the city of ...

VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund 220.62k Jun 30, 2026 1.14% 36,513 Fidelity Concord Street Trust-Fidelity Extended Market Index Fund 95.98k Aug 31, 2026 0.50% 15,884 Fidelity ...

KALA’s recent announcements center on expanding beyond biotechnology into genetic testing, telehealth, preventive care, and healthcare software. The proposed $15 million acquisition remains ...